DescriptionMANAGEMENT AND OPERATION AT SLAC NATIONAL ACCELERATOR LABORATORY
UPDATING SECTION 3610 OF CARES ACT COVERAGE DATE TO 9/30/2021 |
CategoryOperation of Government Owned Contractor-Operated R&D Facilities |
AgencyDepartment of Energy |
SignedMarch 31, 2021 |
Amount Committed$0 |
DescriptionPATHOLOGY AND PATHOGENESIS OF CORONAVIRUS INFECTIONS IN ANIMAL MODELS |
CategoryMedical/Health Special Studies/Analysis |
AgencyFood and Drug Administration |
SignedSeptember 30, 2020 |
Amount Committed$1,550,500 |
DescriptionCOVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS. |
CategoryPhysical Science Applied Research/Exploratory Development R&D |
AgencyNational Institutes of Health |
SignedAugust 28, 2020 |
Amount Committed$14,260,074 |
DescriptionMANAGEMENT AND OPERATION AT SLAC NATIONAL ACCELERATOR LABORATORY
TAS:: 89 0222
COVID-19 PROJECT VALUE: 3013735
B&R CODE: KP $225K |
CategoryOperation of Government Owned Contractor-Operated R&D Facilities |
AgencyDepartment of Energy |
SignedJuly 13, 2020 |
Amount Committed$225,000 |
DescriptionMANAGEMENT AND OPERATION AT SLAC NATIONAL ACCELERATOR LABORATORY
TAS:: 89 0222
COVID-19 PROJECT VALUE: 3013735
B&R CODE: KC $615,000 KP $175,000 TT $21,000 TOTAL $811,000 |
CategoryOperation of Government Owned Contractor-Operated R&D Facilities |
AgencyDepartment of Energy |
SignedJune 29, 2020 |
Amount Committed$11,138,007 |
DescriptionTAS:: 89 0222
TOTAL FUNDING OF $3,849,983.39 IS OBLIGATED IN THIS CONTRACT MODIFICATION AND THE TOTAL OBLIGATION INCLUDES THE COVID-19 FUNDING OF $1,650,000.00 (PROJECT VALUE: 3013735, B&R CODE: KC). |
CategoryOperation of Government Owned Contractor-Operated R&D Facilities |
AgencyDepartment of Energy |
SignedMay 11, 2020 |
Amount Committed$2,755,191 |
DescriptionADD H CLAUSE OF SECTION 3610 UNDER CARES ACT, ETC |
CategoryOperation of Government Owned Contractor-Operated R&D Facilities |
AgencyDepartment of Energy |
SignedApril 30, 2020 |
Amount Committed$0 |
DescriptionTAS:: 89 0222
PROJECT VALUE: 3013735 COVID19 FUNDING OF $825,000.00 (KP $275,000 KC $550,000) WAS OBLIGATED IN THIS MOD. |
CategoryOperation of Government Owned Contractor-Operated R&D Facilities |
AgencyDepartment of Energy |
SignedApril 27, 2020 |
Amount Committed$82,641,490 |
DescriptionADD FAR 52.250-1 INDEMNIFICATION UNDER PUBLIC LAW 85-804 (APR 1984) ALT I (APR 1984) AT I.149 PER THE SECRETARIAL DETERMINATION AUTHORIZING PUBLIC LAW 85-804 INDEMNIFICATION FOR CONTRACTORS ENGAGED IN ACTIVITIES RESPONDING TO COVID-19 (MARCH 26, 2020) AND THE SC POLICY GUIDANCE 2020-21 (APRIL 3, 2020). ADD H.4.3.10 - DEFINITION OF UNUSUALLY HAZARDOUS OR NUCLEAR RISK FOR FAR CLAUSE 52.250-1 INDEMNIFICATION UNDER PUBLIC LAW 85-804&ETC. |
CategoryOperation of Government Owned Contractor-Operated R&D Facilities |
AgencyDepartment of Energy |
SignedApril 15, 2020 |
Amount Committed$0 |
DescriptionTAS:: 89 0321
COVID19 FUNDING OF $50,000 FROM B&R CODE KP1601010 PROJECT VALUE 3013735 |
CategoryOperation of Government Owned Contractor-Operated R&D Facilities |
AgencyDepartment of Energy |
SignedApril 13, 2020 |
Amount Committed$876,890 |
DescriptionBAA SCIENTIFIC STUDY - SEQUELAE AND IMMUNOPATHOLOGY OF EBOLA VIRUS INFECTIONS |
CategoryScientific Data Special Studies/Analysis |
AgencyFood and Drug Administration |
SignedMarch 16, 2020 |
Amount Committed$250,000 |